TechCrunch
plus-bold
TechCrunch
Open Navigation
TechCrunch
Axovant Science
The billion-dollar pharma startup that Silicon Valley has totally missed
Jan 06, 2017
Connie Loizos
If these black marks on the industry are slowing down 31-year-old Vivek Ramaswamy in any way, you wouldn’t know it. He thinks his company, Roivant, will one day be a giant holding company for dozens